Transferrin and transferrin receptors in carcinoma of the breast
Abstract
Breast tissues from 59 patients were immunohistologically studied for transferrin and transferrin receptors. None of the 8 normal breasts or 22 benign mastopathies, and only 1 of 7 fibroadenomas were reactive for transferrin, but 16 (72.7%) of 22 carcinomas were positive and parallel sections showed histopathologically that the rective areas were confined to tumour-cell membranes. That breast-tumour transferrin is probably receptor-bound in vivo was indicatd by its complete chemical removal in vitro and return to the same cells following reincubation with dilute solutions of transferrin. Similar bindig is found on certain normal or transformed cells and at the maternofetal interface of human placentae. It is suggested that this oncofetal receptor preferentially binds apotransferrin and may offer a novel approach to more specific therapy of certain breast cancers.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Upregulation of the Tf/TfR iron acquisition pathway is found in a variety of cancers, including breast and colon.
“Upregulation of this highly conserved iron acquisition pathway is found in a variety of cancers, including breast and colon [90,91,92,93].”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [90]
Cites
Host antigens in schistosomiasis
Smithers, S. R., Terry, R. J., & HOCKLEY, D. J. (1969) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1969.0007 · Cited by 281 · see citing works
Glutaradehyde-activated aminohexyl-derivative of sepharose 4B as a new versatile immunoabsorbent
Cambiaso, C. L., Goffinet, A., Vaerman, J. P., & Heremans, J. F. (1975) · Immunochemistry · doi:10.1016/0019-2791(75)90175-5 · Cited by 217 · see citing works
Hakomori, S., Wang, S.-M., & Young, W. W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.7.3023 · Cited by 181 · see citing works
Faulk, W. P., Temple, A., Lovins, R. E., & SMITH, N. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.4.1947 · Cited by 178 · see citing works
Wada, H., Hass, P. E., & Sussman, H. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86360-3 · Cited by 174 · see citing works
Faulk, W. P., & Johnson, P. (1977) · PubMed · Cited by 134 · see citing works
Transferrin binding by human lymphoblastoid cell lines and other transformed cells
Galbraith, G. M. P., Galbraith, R. M., & Faulk, W. P. (1980) · Cellular Immunology · doi:10.1016/0008-8749(80)90072-6 · Cited by 100 · see citing works
Recent Developments in Immunofluorescence
Faulk, W. P., & Hijmans, W. (2015) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000393067 · Cited by 86 · see citing works
Faulk, W. P., & Galbraith, G. M. P. (1979) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1979.0014 · Cited by 81 · see citing works
Johnson, P., & Faulk, W. P. (1978) · PubMed · Cited by 69 · see citing works
Transferrin Receptor in Human Placental Brush Border Membranes
Wada, H., Hass, P. E., & Sussmang, H. H. (1979) · Cited by 67 · see citing works
Transferrin receptors on the human placental microvillous membrane.
Loh, T. T., Higuchi, D. A., van BOCKXMEER, F. M., Smith, C. H., & Brown, E. B. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109773 · Cited by 64 · see citing works
Immunological studies of transferrin and transferrin receptors of human placental trophoblast
Galbraith, G. M. P., Galbraith, R. M., & Faulk, W. P. (1980) · Placenta · doi:10.1016/s0143-4004(80)80014-2 · Cited by 58 · see citing works
Trophoblast modulation of maternal allogeneic recognition.
McIntyre, J. A., & Faulk, W. P. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.4029 · Cited by 53 · see citing works
A Method for the Use of Immunofluorescence on Paraffin-embedded Tissues
Dorsett, B. H., & Ioachim, H. L. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/69.1.66 · Cited by 50 · see citing works
Transferrin and iron uptake by human cells in culture
Hemmaplardh, D., & MORGAN, E. (1974) · Experimental Cell Research · doi:10.1016/0014-4827(74)90543-6 · Cited by 47 · see citing works
Recent Developments in Immunofluorescence (with colour plates I and II)
Faulk, P., & Hijmans, W. (1972) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000313167 · Cited by 34 · see citing works
Blood group and tissue genetic markers in familial adenocarcinoma: potential specific immunotherapy.
Levine, P. (1978) · PubMed · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., & Torti, F. M. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.08.001 · Cited by 666 · see citing works
Mitochondria regulation in ferroptosis
Wang, H., Liu, C., Zhao, Y., & Gao, G. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.151058 · Cited by 655 · see citing works
Daniels‐Wells, T. R., Delgado, T., Rodríguez, J. A., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 630 · see citing works
Transferrin receptors in human tissues: their distribution and possible clinical relevance.
Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R.-E., & Mason, D. Y. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.5.539 · Cited by 530 · see citing works
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525 · see citing works
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Pinnix, Z. K., Miller, L. D., Wang, W., D’Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001127 · Cited by 448 · see citing works
Mehta, A. M., Sonabend, A. M., & Bruce, J. N. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0520-4 · Cited by 343 · see citing works
Cotten, M. L., Längle-Rouault, F., Kirlappos, H., Wagner, E., Mechtler, K., Zenke, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4033 · Cited by 337 · see citing works
Trowbridge, I. S., & Lopez, F. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.1175 · Cited by 328 · see citing works
Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy
Tortorella, S. M., & Karagiannis, T. C. (2014) · The Journal of Membrane Biology · doi:10.1007/s00232-014-9637-0 · Cited by 316 · see citing works
Biosynthesis of the human transferrin receptor in cultured cells.
Omary, M. B., & Trowbridge, I. S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42979-1 · Cited by 306 · see citing works
Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas
Weaver, M. W., & Laske, D. W. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026246500788 · Cited by 299 · see citing works
Iron as a central player and promising target in cancer progression
Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · see citing works
Trowbridge, I. S., & Domingo, D. L. (1981) · Nature · doi:10.1038/294171a0 · Cited by 275 · see citing works
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Rochette, L., Guénancia, C., Gudjoncik, A., Hachet, O., Zeller, M., Cottin, Y., & Vergely, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.005 · Cited by 251 · see citing works
Iinuma, H., Maruyama, K., Okinaga, K., Sasaki, K., Sekine, T., Ishida, O., Ogiwara, N., Johkura, K., & Yonemura, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10242 · Cited by 216 · see citing works
An iron regulatory gene signature predicts outcome in breast cancer
Miller, L. D., Coffman, L. G., Chou, J. W., Black, M. A., Bergh, J., D'Agostino, R., Torti, S. V., & Torti, F. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1870 · Cited by 202 · see citing works
Balla, J., Vercellotti, G. M., Jeney, V., Yachie, A., Varga, Z., Jacob, H. S., Eaton, J. W., & Balla, G. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1787 · Cited by 212 · see citing works
Choudhury, H., Pandey, M., Chin, P. X., Phang, Y. L., Cheah, J. Y., Ooi, S. C., Mak, K., Pichika, M. R., Kesharwani, P., Hussain, Z., et al. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0552-2 · Cited by 210 · see citing works
Targeting ferroptosis in breast cancer
Li, Z., Chen, L., Chen, C., Zhou, Y., Hu, D., Yang, J., Chen, Y., Zhuo, W., Mao, M., Zhang, X., et al. (2020) · Biomarker Research · doi:10.1186/s40364-020-00230-3 · Cited by 204 · see citing works
Callens, C., Coulon, S., Naudin, J., Radford-Weiss, I., Boissel, N., Raffoux, E., Wang, P. H. M., Agarwal, S., Tamouza, H., Paubelle, E., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091488 · Cited by 197 · see citing works
Habeshaw, J. A., Lister, T. A., Stansfeld, A. G., & Greaves, M. F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92191-8 · Cited by 190 · see citing works
Recht, L. D., Torres, C. O., Smith, T. W., Raso, V., & Griffin, T. W. (1990) · Journal of neurosurgery · doi:10.3171/jns.1990.72.6.0941 · Cited by 184 · see citing works
Widera, A., Norouziyan, F., & Shen, W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.004 · Cited by 173 · see citing works
Torti, S. V., & Torti, F. M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2017 · Cited by 176 · see citing works
A Systems Biology Approach to Iron Metabolism
Chifman, J., Laubenbacher, R., & Torti, S. V. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2095-2_10 · Cited by 175 · see citing works
Kresse, M., Wagner, S., Pfefferer, D., Lawaczeck, R., Elste, V., & Semmler, W. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910400209 · Cited by 161 · see citing works
Rao, V. A., Klein, S. R., Agama, K., Toyoda, E., Adachi, N., Pommier, Y. G., & Shacter, E. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1437 · Cited by 155 · see citing works
The Role of Iron in Cancer Progression
Guo, Q., Li, L., Hou, S., Yuan, Z., Li, C., Zhang, W., Zheng, L., & Li, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.778492 · Cited by 150 · see citing works
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo
Kaptein, S. J. F., Efferth, T., Leis, M., Rechter, S., Auerochs, S., Kalmer, M., Bruggeman, C. A., Vink, C., Stamminger, T., & Marschall, M. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.10.003 · Cited by 148 · see citing works
Does excess iron play a role in breast carcinogenesis? an unresolved hypothesis
Kabat, G. C., & Rohan, T. E. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9058-9 · Cited by 148 · see citing works
Zheng, Y., Yu, B., Weecharangsan, W., Piao, L., Darby, M. V., Mao, Y., Koynova, R. D., Yang, X., Li, H., Xu, S., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.008 · Cited by 133 · see citing works
Studies of the Transferrin Receptor on both Human Reticulocytes and Nucleated Human Cells in Culture
Frazier, J. L., Caskey, J. H., Yoffe, M., & Seligman, P. A. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110525 · Cited by 131 · see citing works
Murine cell surface transferrin receptor: Studies with an anti‐receptor monoclonal antibody
Trowbridge, I. S., Lesley, J., & Schulte, R. J. (1982) · Journal of Cellular Physiology · doi:10.1002/jcp.1041120314 · Cited by 130 · see citing works
Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer
Prutki, M., Poljak‐Blaži, M., Jakopović, M., Tomas, D., Stipančić, I., & Žarković, N. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.001 · Cited by 129 · see citing works
Heme, heme oxygenase and ferritin in vascular endothelial cell injury
Balla, J., Vercellotti, G. M., Jeney, V., Yachie, A., Varga, Z., Eaton, J. W., & Balla, G. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500076 · Cited by 123 · see citing works
Kukulj, S., Jaganjac, M., Boranić, M., Križanac, Š., Šantić, Ž., & Poljak‐Blaži, M. (2009) · Medical Oncology · doi:10.1007/s12032-009-9203-2 · Cited by 121 · see citing works
Anabousi, S., Laue, M. M., Lehr, C., Bakowsky, U., & Ehrhardt, C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.009 · Cited by 115 · see citing works
Inoue, T., Cavanaugh, P. G., Steck, P. A., Brünner, N., & Nicolson, G. L. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560128 · Cited by 115 · see citing works
Moura, I. C. (2004) · Blood · doi:10.1182/blood-2003-07-2440 · Cited by 114 · see citing works
Cellular Iron Metabolism in Health and Diseased
Weinberg, E. D. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539008991450 · Cited by 112 · see citing works
Iron homeostasis in breast cancer
Marques, O., da Silva, B. M., Porto, G., & Lopes, C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.029 · Cited by 115 · see citing works
Laske, D. W., Ilercil, O., Akbaşak, A., Youle, R. J., & Oldfield, E. H. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.3.0520 · Cited by 110 · see citing works
Dysregulation of iron metabolism in cancer stem cells
Recalcati, S., Gammella, E., & Cairo, G. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.015 · Cited by 107 · see citing works
Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells
Sadava, D., Phillips, T., Lin, C., & Kane, S. E. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00005-8 · Cited by 100 · see citing works
Breast Carcinoma and the Role of Iron Metabolism
Elliott, R. L., Elliott, M. C., Wang, F., & Head, J. F. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17204.x · Cited by 99 · see citing works
Lactoferrin and Cancer Disease Prevention
Rodrigues, L. R., Teixeira, J. A., Schmitt, F. C., Paulsson, M. A., & Månsson, H. L. (2008) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390701856157 · Cited by 96 · see citing works
Cellular Iron Metabolism in Prognosis and Therapy of Breast Cancer
Torti, S. V., & Torti, F. M. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013007784 · Cited by 93 · see citing works
Simonart, T., Heenen, M., Degraef, C., Andreï, G., Mosselmans, R., Hermans, P., Vooren, J. V., Noël, J., Boelaert, J. R., & Snoeck, R. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00119.x · Cited by 92 · see citing works
Physical characterization of the transferrin receptor in human placentae.
Enns, C. A., & Sussman, H. H. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68700-4 · Cited by 88 · see citing works
Intraventricular Immunotoxin Therapy for Leptomeningeal Neoplasia
Laske, D. W., Muraszko, K. M., Oldfield, E. H., DeVroom, H. L., Sung, C., Dedrick, R. L., Simon, T. R., Colandrea, J., Copeland, C., Katz, D., et al. (1997) · Neurosurgery · doi:10.1097/00006123-199711000-00005 · Cited by 87 · see citing works
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator
Abeysinghe, R. D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1607 · Cited by 83 · see citing works
Kondo, K., Noguchi, M., Mukai, K., Matsuno, Y., Sato, Y., Shimosato, Y., & Monden, Y. (1990) · CHEST Journal · doi:10.1378/chest.97.6.1367 · Cited by 82 · see citing works
Ng, P. P., Cruz, J. S. D., Sorour, D. N., Stinebaugh, J. M., Shin, S.-U., Shin, D. S., Morrison, S. L., & Penichet, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162362999 · Cited by 81 · see citing works
Zovickian, J. G., Johnson, V. G., & Youle, R. J. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.66.6.0850 · Cited by 80 · see citing works
Turner, J. (2005) · Blood · doi:10.1182/blood-2005-03-1263 · Cited by 76 · see citing works
Selective stimulation of prostatic carcinoma cell proliferation by transferrin.
Rossi, M. C., & Zetter, B. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6197 · Cited by 77 · see citing works
Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatment
Voth, B. L., Nagasawa, D. T., Pelargos, P. E., Chung, L. K., Ung, N. M., Gopen, Q. S., Tenn, S. E., Kamei, D. T., & Yang, I. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.02.002 · Cited by 76 · see citing works
Transferrin receptors of human fibroblasts. Analysis of receptor properties and regulation
Ward, J. H., Kushner, J. P., & Kaplan, J. (1982) · Biochemical Journal · doi:10.1042/bj2080019 · Cited by 75 · see citing works
Gorbunov, N. V., Yalowich, J. C., Gaddam, A., Thampatty, P., Ritov, V. B., Kisin, E. R., Elsayed, N. M., & Kagan, V. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12328 · Cited by 75 · see citing works
Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue
Rossiello, R., Carriero, M. V., & Giordano, G. G. (1984) · Journal of Clinical Pathology · doi:10.1136/jcp.37.1.51 · Cited by 72 · see citing works
Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA.
Barabás, K., SIZENSKY, J. A., & Faulk, W. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50442-2 · Cited by 71 · see citing works
Preparation, biodistribution, and small animal PET of 45Ti-transferrin.
Vāvere, A. L., & Welch, M. J. (2005) · PubMed · Cited by 70 · see citing works
Enns, C. A., Shindelman, J. E., Tonik, S. E., & Sussman, H. H. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4222 · Cited by 70 · see citing works
Tumor-Targeted and Clearable Human Protein-Based MRI Nanoprobes
Zhao, Y., Peng, J., Li, J., Huang, L. F., Yang, J., Huang, K., Li, H., Jiang, N., Zheng, S., Zhang, X., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b00828 · Cited by 67 · see citing works
FitzGerald, D. J., Willingham, M. C., & PASTAN, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6627 · Cited by 66 · see citing works
Hepcidin and its therapeutic potential in neurodegenerative disorders
Qian, Z., & Ke, Y. (2019) · Medicinal Research Reviews · doi:10.1002/med.21631 · Cited by 63 · see citing works
Jones, D. T., Trowbridge, I. S., & Harris, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3857 · Cited by 75 · see citing works
Current understandings and clinical translation of nanomedicines for breast cancer therapy
Jiang, Y., Jiang, Z., Wang, M., & Ma, L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114034 · Cited by 65 · see citing works
Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells
Laptev, R., Nisnevitch, M., Siboni, G., Malik, Z., & Firer, M. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603241 · Cited by 64 · see citing works
Transferrin receptor expression in non‐malignant and malignant human breast tissue
Walker, R. A., & Day, S. J. (1986) · The Journal of Pathology · doi:10.1002/path.1711480305 · Cited by 64 · see citing works
Callens, C., Moura, I. C., Lepelletier, Y., Coulon, S., Renand, A., Dussiot, M., Ghez, D., Benhamou, M., Monteiro, R. C., Bazarbachi, A. A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404958 · Cited by 62 · see citing works
Autoantibodies unmasked by redox reactions
McIntyre, J. A., Wagenknecht, D. R., & Faulk, W. P. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.03.005 · Cited by 62 · see citing works
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.
FitzGerald, D. J., Bjorn, M. J., Ferris, R. J., Winkelhake, J. L., Frankel, A. E., Hamilton, T. C., Ozols, R. F., Willingham, M. C., & Pastan, I. H. (1987) · PubMed · Cited by 62 · see citing works
Lipocalin-2 and iron trafficking in the tumor microenvironment
Jung, M., Mertens, C., Bauer, R., Rehwald, C., & Brüne, B. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.018 · Cited by 60 · see citing works
Transferrin Receptor Expression and the Control of Cell Growth
Neckers, L. Μ., & Trepel, J. B. (1986) · Cancer Investigation · doi:10.3109/07357908609017524 · Cited by 61 · see citing works
Antibody-Based Immunotoxins for the Treatment of Cancer
Becker, N., & Benhar, I. (2012) · Antibodies · doi:10.3390/antib1010039 · Cited by 61 · see citing works
Singh, M., Mugler, K. C., Hailoo, D. W., Burke, S., Nemesure, B. B., Torkko, K. C., & Shroyer, K. R. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e318209716e · Cited by 60 · see citing works
Up-regulation of vascular endothelial growth factor production by iron chelators.
Beerepoot, L. V., Shima, D. T., Kuroki, M., Yeo, K. T., & Voest, E. E. (1996) · PubMed · Cited by 60 · see citing works
Yeh, C. G., Papamichael, M., & Faulk, W. P. (1982) · Experimental Cell Research · doi:10.1016/0014-4827(82)90192-6 · Cited by 60 · see citing works
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.
Taverne, J., Matthews, N., Depledge, P., & Playfair, J. H. L. (1984) · PubMed Central · Cited by 60 · see citing works
Kvaløy, S., Langholm, R., Kaalhus, O., Michaelsen, T. E., Funderud, S., Abrahamsen, A. F., & Godal, T. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330204 · Cited by 58 · see citing works
Human amniochorion: Tissue-specific markers, transferrin receptors and histocompatibility antigens
Hsi, B., Yeh, C. G., & Faulk, W. P. (1982) · Placenta · doi:10.1016/s0143-4004(82)80012-x · Cited by 58 · see citing works
Iron homeostasis and anemia markers in early breast cancer
Lamy, P., Durigova, A., & Jacot, W. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.04.011 · Cited by 57 · see citing works
Transferrin-Mediated Targeting of Bacteriophage HK97 Nanoparticles Into Tumor Cells
Huang, R. K., Steinmetz, N. F., Fu, C., Manchester, M., & Johnson, J. E. (2010) · Nanomedicine · doi:10.2217/nnm.10.99 · Cited by 57 · see citing works
Iron transport kinetics through blood-brain barrier endothelial cells
Khan, A. I., Liu, J., & Dutta, P. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.02.010 · Cited by 57 · see citing works
Ng, P. P., Helguera, G. F., Daniels‐Wells, T. R., Lomas, S. Z., Rodríguez, J. A., Schiller, G. J., Bonavida, B., Morrison, S. L., & Penichet, M. L. (2006) · Blood · doi:10.1182/blood-2006-04-020263 · Cited by 56 · see citing works
Targeting Receptors, Transporters and Site of Absorption to Improve Oral Drug Delivery
Hamman, J. H., Demana, P. H., & Olivier, E. I. (2007) · Drug Target Insights · doi:10.1177/117739280700200003 · Cited by 55 · see citing works
(C) Means to enhance penetration
Shen, W., Wan, J., & Ekrami, H. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90016-j · Cited by 55 · see citing works
Regulation of the hepatic transferrin receptor in hereditary hemochromatosis†
Lombard, M. G., Bomford, A. B., Hynes, M., Naoumov, N. V., Roberts, S., Crowe, J., & Williams, R. L. (1989) · Hepatology · doi:10.1002/hep.1840090102 · Cited by 54 · see citing works
In vivo gene delivery to tumor cells by transferrin‐streptavidin‐DNA conjugate
Sato, Y., Yamauchi, N., Takahashi, M., Sasaki, K., Fukaura, J., Neda, H., Fujii, S., Hirayama, M., Itoh, Y., Koshita, Y., et al. (2000) · The FASEB Journal · doi:10.1096/fj.99-1052com · Cited by 53 · see citing works
Selection and properties of a mouse L-cell transformant expressing human transferrin receptor
Newman, R., Domingo, D. L., Trotter, J., & Trowbridge, I. S. (1983) · Nature · doi:10.1038/304643a0 · Cited by 53 · see citing works
Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway
Cui, C., Cheng, X., Yan, L., Ding, H., Guan, X., Zhang, W., Tian, X., & Hao, C. (2019) · Cancer Management and Research · doi:10.2147/cmar.s198911 · Cited by 51 · see citing works
In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme
Hall, W. A., Godál, A., Juell, S., & Fodstad, Ø. (1992) · Journal of neurosurgery · doi:10.3171/jns.1992.76.5.0838 · Cited by 50 · see citing works
Similarities between the transferrin receptor proteins on human reticulocytes and human placentae.
Enns, C. A., & Sussman, H. H. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42934-1 · Cited by 50 · see citing works
Color Doppler Ultrasound and Gamma Imaging of Intratumorally Injected 500 nm Iron–Silica Nanoshells
Liberman, A., Wu, Z. B., Barback, C. V., Viveros, R. D., Blair, S. L., Ellies, L. G., Vera, D. R., Mattrey, R. F., Kummel, A. C., & Trogler, W. C. (2013) · ACS Nano · doi:10.1021/nn402507d · Cited by 48 · see citing works
Distribution of the transferrin receptor in normal human fibroblasts and fibrosarcoma cells
Ekblom, P., Thesleff, I., Lehto, V., & Virtanen, I. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310118 · Cited by 48 · see citing works
Jamnongkan, W., Thanan, R., Techasen, A., Namwat, N., Loilome, W., Intarawichian, P., Titapun, A., & Yongvanit, P. (2017) · Tumor Biology · doi:10.1177/1010428317717655 · Cited by 47 · see citing works
Elnahas, M. O., Amin, M. A., Hussein, M., Shanbhag, V., Ali, A. E., & Wall, J. D. (2017) · Molecules · doi:10.3390/molecules22091396 · Cited by 47 · see citing works
Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma
Wu, H., Zhang, J., Dai, R., Xu, J., & Feng, H. (2019) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-019-1301-z · Cited by 47 · see citing works
- Authors
- Page Faulk, W., Hsi, B.-L., & Stevens, P. J.
- Affiliations
- Queen Victoria Hospital (GB)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1980-08
- Volume
- 316
- Issue
- 8191
- Pages
- 390-392
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2079229575
- Cited by
- 280
- References
- 18
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 8 · 2018: 5 · 2017: 8 · 2015: 3 · 2014: 8 · 2013: 6 · 2012: 8
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
- Keywords
- transferrin, transferrin receptor, breast cancer, apotransferrin, oncofetal protein, tumor cell membrane, fibroadenoma, benign breast disease, breast cancer treatment
- MeSH terms
- Breast, Breast Neoplasms, Cell Membrane, Female, Fetal Proteins, Fluorescent Antibody Technique, Humans, Receptors, Cell Surface, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review